SEC Comment Letter for Itamar Medical Ltd. (CIK 0001613170) — Jan 28, 2020
Itamar Medical Ltd. (CIK 0001613170)
Date: Jan. 28, 2020 · CIK: 0001613170 · Accession: 0000000000-20-000723
AI Filing Summary & Sentiment
Letter
January 27, 2020 Gilad Glick Chief Executive Officer Itamar Medical Ltd. 3290 Cumberland Club Drive Atlanta, GA 30339 Re:Itamar Medical Ltd. Draft Registration Statement on Form F-1 Submitted January 14, 2020 CIK No. 0001613170 Dear Mr. Glick: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nathan Ajiashvili - Latham & Watkins LLP
Show Raw Text
January 27, 2020
Gilad Glick
Chief Executive Officer
Itamar Medical Ltd.
3290 Cumberland Club Drive
Atlanta, GA 30339
Re:Itamar Medical Ltd.
Draft Registration Statement on Form F-1
Submitted January 14, 2020
CIK No. 0001613170
Dear Mr. Glick:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nathan Ajiashvili - Latham & Watkins LLP